Balaxi
Live Price
Recent news and updates for BALAXI will appear here soon.
"Balanced market signals for BALAXI. The stock is currently consolidating with neutral technical indicators and fundamental alignment between current healthcare growth rates and prevailing valuation metrics."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceutical products in India and internationally. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.
As of the latest market session, Balaxi (BALAXI) is trading at ₹19.15, representing a move of -2.84% from the previous close.
Balaxi is listed and traded under the ticker symbol BALAXI on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Balaxi's stock price moved by -2.84%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 50% bullish probability for BALAXI stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Balaxi shares reached a high of ₹43.85 and hit a low of ₹15.2.
BALAXI exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 21,377 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Balaxi has a market capitalization of ₹108.15 Cr, designating its size class inside the Healthcare sector.
Balaxi has a current dividend yield of N/A. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Balaxi's trailing Price-to-Earnings (P/E) ratio is 43.53. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Balaxi (BALAXI) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Balaxi's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore BALAXI's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for BALAXI are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Balaxi operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.